Paper224898
Modulation of transferrin receptors in bone marrow cells by changes in lipid fluidity.
Muller C and 1 other. Br J Haematol, 1979. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Modulation of transferrin receptors in bone marrow cells by changes in lipid fluidity. Papers, record 224898. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/224898
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow | Major topic |
| Membrane Fluidity | Major topic |
| Membrane Lipids | Major topic |
| Receptors, Cell Surface | Major topic |
| Transferrin | Major topic |
| Animals | |
| Binding Sites | |
| Bone Marrow Cells | |
| Cholesterol | |
| Hematopoiesis | |
| In Vitro Techniques | |
| Mice | |
| Microscopy, Fluorescence | |
| Protein Binding | |
| Temperature | |
| Viscosity |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 10198050 | Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. | Mol Biol Cell | 1999 | https://conductscience.org/library/papers/10198050 | PubMed |
| 6938985 | Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6938985 | PubMed |
| 6323541 | Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6323541 | PubMed |
| 6310554 | Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6310554 | PubMed |
| 6256749 | Prostaglandin I2 modifies both prolactin binding capacity and fluidity of mouse liver membranes. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6256749 | PubMed |
| 6159095 | Correlation between cell density, membrane fluidity, and the availability of transferrin receptors in Friend erythroleukemic cells. | Cell Biophys | 1980 | https://conductscience.org/library/papers/6159095 | PubMed |
| 3653928 | Increased fucosylation of glycolipids in a human leukaemia cell line (K562-Clone I) with decreased sensitivity to NK-mediated lysis. | Immunology | 1987 | https://conductscience.org/library/papers/3653928 | PubMed |
| 116228 | Effective tumor immunization induced by cells of elevated membrane-lipid microviscosity. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/116228 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TF | 7018 | PubTator's text mining | https://conductscience.org/library/genes/7018 | NCBI Gene |
| TFRC | 7037 | PubTator's text mining | https://conductscience.org/library/genes/7037 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/224898
GET https://conductscience.org/api/papers/v1/224898/authors